Associated Papers
Renal and multisystem effectiveness of 3.9 years of migalastat in a global real-world cohort: Results from the followME Fabry Pathfinders registry.
Hughes DA et al.
Journal of Inherited Metabolic Disease, 2025
39031114 (PubMed )
Supplement: JIMD-48-0-s001.docx
What Is the Role of Sensorineural Hearing Loss in Fabry Disease Screening?
Köroğlu EY et al.
Turkish Archives of Otorhinolaryngology, 2023
Long-Term Monitoring of Cardiac Involvement under Migalastat Treatment Using Magnetic Resonance Tomography in Fabry Disease.
Gatterer C et al.
Life (basel, Switzerland), 2023
Sphingosine-1-Phosphate Levels Are Higher in Male Patients with Non-Classic Fabry Disease.
Mauhin W et al.
Journal of Clinical Medicine, 2022
Parsing Fabry Disease Metabolic Plasticity Using Metabolomics.
Ducatez F et al.
Journal of Personalized Medicine, 2021
34575675 (PubMed )
Supplement: jpm-11-00898-s001.zip › Ducatez_et_al_supp_data_fabomics_20210731.xlsx › Table_S2
Cornea verticillata and acroparesthesia efficiently discriminate clusters of severity in Fabry disease.
Mauhin W et al.
Plos One, 2020
Peripheral nerve involvement in Fabry's disease: Which investigations? A case series and review of the literature.
Franques J et al.
Revue Neurologique, 2017
Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics.
Favalli V et al.
Journal of the American College of Cardiology, 2016
Select a paper to view details